» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

PSYENCE GROUP

WVB Number : CAN000030526 Country : Canada
SIC categorization : MEDICINAL CHEMS,BOTANICL PDS (2833) ISIN : CA74449Q1063
FT categorization : HEALTH CARE (431)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. Psyence has built and operates one of the first federally licensed commercial psilocybin cultivation and production facilities.
Phone : 1 4164771708 Fax :
Chairman: : JODY AUFRICHTIG Auditor : MNP LLP
CEO/Managing Director : JODY AUFRICHTIG

» Company Facts

Net Profit Margin (%) N/A  
Operating Margin (%) N/A  
Return on Assets (%) -69.43  
Return on Equity (%) -274.63  
Employees N/A  

» Company Financials

  Annual (2020)
Income Statement
('000 CAD )
Sales/Total Revenue 0  
EBITDA -92  
EBIT -92  
Net Income -92  
Balance Sheet
( '000 CAD)
Total Current Assets 124  
Total Assets 124  
Current Liabilities 137  
Total Liabilities & Debt 137  
Total Equity -13  
Cash & Flow
( '000 CAD)
Net Income/Staring Line -92  
Cash from Operating -46  
Cash from Investing 0  
Cash from Financing 30  
Cash & Equivalent Yr End 125